The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

Non-coding RNAs (ncRNAs), once considered the 'dark matter' of the genome, have now emerged as pivotal regulators in cancer ...

Natural killer cells aren't just mindless defenders — a special type, adaptive NK cells, remember their enemies and come back ...

Emma Weston joined the clinical trial after running out of treatment options. For two years, she's been cancer free.

Adoptive cell therapy based on ex-vivo expanded tumor-infiltrating lymphocytes (TILs) has historically been most effective in the treatment of metastatic melanoma,1 with objective response rates of up ...

Medicine is capable of detecting cancer and identifying how cancers might resist treatment. Here are four things to know about the test: Read the full study here.

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

There are few things more frustrating than experiencing a poor signal on your cell phone. From dropped calls to messages that won’t send and streaming services that stutter and die, a lack of ...

Researchers are unsure of the exact cause of prostate cancer. It develops when specific changes occur, usually in glandular cells. When prostate gland cells appear abnormal, a doctor may refer to ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for treating cachexia and brain-related diseases. Researchers at Oregon State Un ...

“Ten to 15 percent of the cells were tumor cells,” said Rominiyi. Despite the surgical teams’ best efforts to capture as much of the cancer as possible, the tumors usually reappear within a year. 4 ...